The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.
|Publisher||University of Basel, Switzerland|
|Current Email||Visible to members|
Drug resistance can be defined as the failure of a drug to exert its expected effect on pharmacological biomarkers and is caused by pharmacogenetic, cellular or clinical factors. Non-adherence, a common challenge in chronic outpatient therapy, and drug drug interactions (DDI) constitute two major clinical factors that contribute to drug resistance. Both can be controlled by a new technology for electronic multidrug adherence monitoring that was developed in the framework of this thesis.